Related Experiment Video
Updated: Sep 5, 2025

08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
9.2K
Genome-wide RNA interference screen in cancer stem cells
Guillaume Pinna1, Marie Vandamme1, Celia Rouault2
1Plateforme ARN interférence (PARi), Université Paris Cité & Université Paris-Saclay, Inserm, iRCM/IBFJ CEA, Stabilité Génétique Cellules Souches et Radiations, Fontenay-aux-Roses, France.
Methods in Cell Biology
|July 10, 2022
Summary
This study introduces a high-throughput screening method to identify factors influencing cancer stem cells (CSCs). This approach aids in developing novel therapeutic strategies for various cancers by targeting CSCs.
Area of Science:
- Oncology
- Cancer Biology
- Stem Cell Research
Background:
- Tumor heterogeneity, driven by cancer stem cells (CSCs), is a significant obstacle in cancer therapy and is linked to poor patient prognosis.
- Understanding the molecular mechanisms that regulate stemness in CSCs is crucial for developing effective cancer treatments.
Purpose of the Study:
- To establish a high-throughput screening (HTS) strategy for identifying modulators of cancer stem cell (CSC) populations.
- To provide a detailed protocol for this HTS approach, enabling broader application in cancer research.
Main Methods:
- A miniaturized ALDEFLUOR-based CSC assay was employed, utilizing high-content imaging for quantitative analysis.
- Genome-wide RNA interference (RNAi) libraries were used to induce gene loss-of-function and assess its impact on CSC proportions.
Main Results:
- The developed HTS strategy effectively monitors changes in CSC proportions in response to gene silencing.
- The protocol allows for the quantitative assessment of CSC modulation through high-content imaging.
Conclusions:
- Genome-wide HTS strategies, like the one presented, are powerful tools for discovering novel therapeutic targets in cancer.
- This method facilitates the identification of new therapeutic approaches aimed at controlling CSC populations and improving cancer treatment outcomes.
Related Concept Videos
Experimental RNAi
6.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.2K
RNA Interference
26.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.4K

